1. What is already known about this subject:
- Inconsistent doses of Hydroxychloroquine are included in national guidelines and clinical studies protocols for management of COVID-19 disease.
- Modelling and simulation approaches have recently been proposed for dose selection but (external) clinical validation was either lacking or carrying important limitations and unverified assumptions.